Get the Stockscreener App
6.15
5.49%
0.32
Ardelyx Inc stock is traded at $6.15, with a volume of 8.28M.
It is up +5.49% in the last 24 hours and up +11.01% over the past month.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
See More
Previous Close:
$5.83
Open:
$5.84
24h Volume:
8.28M
Relative Volume:
2.44
Market Cap:
$1.49B
Revenue:
$386.15M
Net Income/Loss:
$-56.39M
P/E Ratio:
-26.74
EPS:
-0.23
Net Cash Flow:
$-55.19M
1W Performance:
+7.14%
1M Performance:
+11.01%
6M Performance:
+46.78%
1Y Performance:
+20.12%
1-Day Range:
$5.81
$6.3998
1-Week Range:
$5.69
$6.3998
52-Week Range:
$3.21
$6.78
Ardelyx Inc Stock (ARDX) Company Profile
Name
Ardelyx Inc
Sector
Industry
Phone
510-745-7047
Address
34175 ARDENWOOD BLVD., FREMONT, CA
Compare ARDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
6.15 | 1.42B | 386.15M | -56.39M | -55.19M | -0.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Resumed | Raymond James | Strong Buy |
| Jun-18-25 | Resumed | H.C. Wainwright | Buy |
| May-02-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-07-25 | Resumed | Ladenburg Thalmann | Buy |
| Mar-04-25 | Initiated | BTIG Research | Buy |
| Nov-11-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-02-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-05-24 | Initiated | Leerink Partners | Outperform |
| Dec-18-23 | Initiated | Raymond James | Strong Buy |
| Sep-07-23 | Initiated | H.C. Wainwright | Buy |
| Aug-25-23 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Mar-03-23 | Upgrade | Wedbush | Neutral → Outperform |
| Nov-17-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| May-06-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Dec-01-21 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Oct-14-21 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jul-21-21 | Downgrade | Jefferies | Buy → Hold |
| Jul-20-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-21 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-23-21 | Initiated | Wedbush | Outperform |
| Jan-06-21 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-20-20 | Resumed | Citigroup | Buy |
| Feb-18-20 | Resumed | Jefferies | Buy |
| Feb-12-20 | Initiated | Citigroup | Buy |
| Feb-10-20 | Initiated | Cowen | Outperform |
| Apr-08-19 | Initiated | Piper Jaffray | Overweight |
| Aug-24-18 | Initiated | Jefferies | Buy |
| Mar-19-18 | Resumed | Leerink Partners | Outperform |
| Nov-29-17 | Reiterated | Citigroup | Buy |
| Nov-22-17 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-17-17 | Resumed | Leerink Partners | Outperform |
| Mar-31-16 | Initiated | Ladenburg Thalmann | Buy |
| Mar-09-16 | Initiated | Cantor Fitzgerald | Buy |
| Mar-03-16 | Initiated | Citigroup | Buy |
View All
Ardelyx Inc Stock (ARDX) Latest News
Ardelyx Shares Surge Following Strategic Clinical Update - timothysykes.com
Ardelyx Stock Rises Amid Market Developments - timothysykes.com
Raymond James reiterates Strong Buy on Ardelyx stock after price increases - Investing.com Nigeria
Ardelyx (ARDX) Boosts Product Prices, Shares Climb - GuruFocus
Ardelyx rises amid report on price hikes for lead product - MSN
Ardelyx stock jumps as Raymond James notes price hikes - Investing.com
Ardelyx stock jumps as Raymond James notes price hikes By Investing.com - Investing.com Australia
Ardelyx gains on price hikes for lead product (ARDX:NASDAQ) - Seeking Alpha
Jobs Data: Will Ardelyx Inc 41X stock outperform global peers2025 AllTime Highs & Expert Verified Movement Alerts - moha.gov.vn
Ardelyx Inc Stock Analysis and ForecastEarnings Growth Projections & Chat With Other Investors on Daily Signals - earlytimes.in
Ardelyx Insider Ups Holding By 19% During Year - Yahoo Finance
Trend Report: Why Ardelyx Inc stock is in analyst buy zoneQuarterly Investment Review & Reliable Intraday Trade Alerts - moha.gov.vn
Squarepoint Ops LLC Takes $708,000 Position in Ardelyx, Inc. $ARDX - MarketBeat
Do Ardelyx’s (ARDX) Leadership Changes Reframe How Investors View Its Long-Term Pipeline Strategy? - simplywall.st
Ardelyx, Inc. (NASDAQ:ARDX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Ardelyx (ARDX): Revisiting Valuation After a Strong Multi‑Year Shareholder Return Run - simplywall.st
Market Wrap: Why The Gabelli Utility Trust Equity Right stock remains a top recommendationMarket Activity Report & Verified Stock Trade Ideas - moha.gov.vn
How Ardelyx Inc. stock compares to market leadersAnalyst Downgrade & Verified Chart Pattern Trade Signals - Улправда
How Ardelyx Inc. (41X) stock reacts to weak economy2025 Top Decliners & Low Risk High Win Rate Stock Picks - Улправда
How Ardelyx Inc. (41X) stock reacts to fiscal policiesJuly 2025 Volume & AI Enhanced Trading Alerts - Улправда
Aug Big Picture: Can Ardelyx Inc. stock hit analyst price targetsJuly 2025 Recap & Daily Oversold Bounce Ideas - Улправда
How resilient is Ardelyx Inc. stock in market downturnsJuly 2025 Momentum & Low Risk Growth Stock Ideas - Улправда
Can Ardelyx Inc. stock hit analyst price targetsJuly 2025 Opening Moves & Free Daily Entry Point Trade Alerts - Улправда
Ardelyx, Inc.'s (NASDAQ:ARDX) Institutional Investors Lost 8.5% Last Week but Have Benefitted From Longer-term Gains - 富途牛牛
Why Ardelyx Inc. stock is in analyst buy zone2025 Buyback Activity & Free Real-Time Market Sentiment Alerts - DonanımHaber
What analyst consensus says on Ardelyx Inc. stockTrade Signal Summary & Weekly Momentum Picks - DonanımHaber
Should I hold or sell Ardelyx Inc. stock in 20252025 Price Targets & Weekly High Potential Stock Alerts - Улправда
Ardelyx Announces Key Leadership Transitions - The Globe and Mail
Ardelyx announces executive departures and leadership transitions By Investing.com - Investing.com Canada
Ardelyx announces executive departures and leadership transitions - Investing.com
Ardelyx Inc. Reports Strong Q3 Earnings Growth - MSN
Ardelyx Announces Resignation of Chief Legal and Administrative Officer - TradingView — Track All Markets
Ardelyx (NASDAQ: ARDX) details C-suite resignations and 24-month advisory role - Stock Titan
Ardelyx (NASDAQ:ARDX) Trading Up 6.2%Still a Buy? - MarketBeat
Ardelyx, Inc.'s (NASDAQ:ARDX) Path To Profitability - simplywall.st
Ardelyx stock price target raised to $16 from $15 at Raymond James By Investing.com - Investing.com South Africa
Ardelyx stock price target raised to $16 from $15 at Raymond James - Investing.com Australia
Can Garware Hi Maintain Growth Without Diluting ShareholdersEarnings Forecast Updates & Minimal Investment Trading - earlytimes.in
Aug Swings: Will Ardelyx Inc stock benefit from AI adoptionTrade Volume Summary & Accurate Intraday Trading Signals - moha.gov.vn
Ardelyx, Inc.'s (NASDAQ:ARDX) Shift From Loss To Profit - Yahoo Finance
Marshall Wace LLP Raises Stock Position in Ardelyx, Inc. $ARDX - MarketBeat
Ardelyx Inc Stock (ARDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Ardelyx Inc Stock (ARDX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| RAAB MICHAEL | President & CEO |
Nov 21 '25 |
Sale |
5.54 |
46,887 |
259,609 |
1,455,363 |
| Kelliher Mike | See Remarks |
Nov 21 '25 |
Sale |
5.54 |
5,560 |
30,785 |
271,181 |
| Williams Laura A | Chief Patient Officer |
Nov 21 '25 |
Sale |
5.54 |
6,426 |
35,580 |
359,896 |
| Foster Eric Duane | Chief Commercial Officer |
Nov 21 '25 |
Sale |
5.54 |
5,814 |
32,192 |
295,684 |
| Reilly Joseph James | See Remarks |
Nov 21 '25 |
Sale |
5.54 |
11,086 |
61,382 |
108,914 |
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):